These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4612885)

  • 21. A randomized prospective study of cadaver donor pretreatment in renal transplantation.
    Jeffery JR; Downs A; Grahame JW; Lye C; Ramsey E; Thomson AE
    Transplantation; 1978 Jun; 25(6):287-9. PubMed ID: 351886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolongation of canine renal allografts in the immunosuppressed host by donor pretreatment with cytolytic agents.
    McCabe R; Swistel A; Lorieo D; Fitzpatrick HF
    Transplant Proc; 1980 Jun; 12(2):355-7. PubMed ID: 6156529
    [No Abstract]   [Full Text] [Related]  

  • 23. Canine renal preservation following hypothermic perfusion and subsequent function.
    Scott DF; Morley AR; Swinney J
    Br J Surg; 1969 Sep; 56(9):688-91. PubMed ID: 4897217
    [No Abstract]   [Full Text] [Related]  

  • 24. Donor pretreatment in cadaver renal transplantation.
    Zincke H; Woods JE
    Surg Gynecol Obstet; 1977 Aug; 145(2):183-8. PubMed ID: 327596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment of cadaver donors with cyclophosphamide and methylprednisolone: effect on renal transplant outcome.
    Corry RJ; Patel NP; West JC; Schanbacher BA
    Transplant Proc; 1980 Jun; 12(2):348-51. PubMed ID: 6994305
    [No Abstract]   [Full Text] [Related]  

  • 26. Humoral factors in canine renal allograft rejection.
    Clark DS; Foker JE; Good RA; Varco RL
    Lancet; 1968 Jan; 1(7532):8-10. PubMed ID: 4169109
    [No Abstract]   [Full Text] [Related]  

  • 27. Early changes in drug-modified renal allografts in dogs.
    Sheil AG; Dammin GJ; Mitchell RM; Murray JE
    Br J Surg; 1967 Dec; 54(12):1013-6. PubMed ID: 4864073
    [No Abstract]   [Full Text] [Related]  

  • 28. Donor pretreatment on perfused cadaver kidneys: experimental observations.
    Sy G; Taiyebb S; Toledo-Pereyra LH
    Am Surg; 1981 Jul; 47(7):307-8. PubMed ID: 7020513
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.
    Burleson RL; Jones DB; Yenikomshian A; DeVoe C; DeRito J
    Transplant Proc; 1977 Sep; 9(3):1591-6. PubMed ID: 331594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attempted antigenic alteration of canine kidneys by 24- or 48-hr perfusion with immunosuppressive agents.
    Woods JE; Cooperman AM; Holley KE
    Transplantation; 1972 Mar; 13(3):336. PubMed ID: 4553735
    [No Abstract]   [Full Text] [Related]  

  • 31. Donor pretreatment in an unselected series of cadaver renal allografts.
    Guttmann RD; Morehouse DD; Meakins JL; Klassen J; Knaack J; Beaudoin JG
    Kidney Int Suppl; 1978 Jun; (8):S99-102. PubMed ID: 357821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of peripheral blood leukocyte activity following canine renal allotransplantation.
    Pauly JL; Varkarakis MJ; Germain MJ; Murphy GP
    J Med; 1974; 5(5):221-8. PubMed ID: 4606248
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal preservation. A modified solution for 18 hours of protection.
    Netto IC; Basso AG; Cockett AT
    Urology; 1973 Oct; 2(4):389-92. PubMed ID: 4584861
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro alteration of canine renal allograft immunogenicity.
    Waltzer WC; Zincke H; Sterioff S; Holley KE; Offord KP; Matsuura JK
    Transplantation; 1980 Mar; 29(3):249-51. PubMed ID: 6987791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
    Wren SF; Martins AC; Von Haefen U; Busch GJ; Katske GE; Koppenheffer TL; Shaipanich T; Wilson RE
    Surgery; 1974 Jul; 76(1):112-20. PubMed ID: 4135410
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolongation of canine renal allograft survival with antilymphocytic serum.
    Clunie GJ; Nolan B; James K; Watt JG; Woodruff MF
    Transplantation; 1968 May; 6(3):459-67. PubMed ID: 4172547
    [No Abstract]   [Full Text] [Related]  

  • 37. Attempted renal allograft enhancement by pooled kidney antigen pretreatment.
    Stephens FO; Cochrum KC; Scott DF; Price DC; Belzer FO
    Ann Surg; 1972 Jan; 175(1):41-7. PubMed ID: 4551347
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined effect of recipient blood transfusion and donor pretreatment with cyclophosphamide and methylprednisolone.
    Corry RJ; West JC
    Transplant Proc; 1981 Mar; 13(1 Pt 1):161-3. PubMed ID: 7022814
    [No Abstract]   [Full Text] [Related]  

  • 39. Allogeneic canine bone marrow transplantation following cyclophosphamide.
    Storb R; Epstein RB; Rudolph RH; Thomas ED
    Transplantation; 1969 May; 7(5):378-86. PubMed ID: 4890905
    [No Abstract]   [Full Text] [Related]  

  • 40. Accelerated renal allograft rejection following blood transfusion.
    Bradley KP; McElroy JT; Campbell F; De Quesada AM; Shires DL; Biegel AA; Donohue JP; Glover JL
    Surgery; 1971 May; 69(5):805-9. PubMed ID: 4930257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.